6-Methyleneandrost-4-ene-3,17-Dione CAS 19457-55-7 Exemestane Intermedia Puritas >99.0% (HPLC) Factory
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum 6-Methyleneandrost-4-ene-3,17-Dione (1,2-Dihydro Exemestane) (CAS: 19457-55-7) cum qualitate, media Exemestane (CAS: 107868-30-4).CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interest 6-Methyleneandrost-4-ene-3,17-Dionem;Please contact: alvin@ruifuchem.com
| Nomen chemicum | 6-Methyleneandrost-4-ene-3,17-Dione |
| Synonyma | 1,2-Dihydro Exemestane;6-Methylene-4-Androstene-3,17-Dione |
| immunditia | Exemestane EP, Impuritas E;Exemestane USP Related Compone A |
| Stock Status | In Stock, Productio Capacity 20 Tons per Month |
| CAS Number | 19457-55-7 |
| Formulae hypotheticae | C20H26O2 |
| M. Pondus | 298.43 |
| Liquescens punctum | ≥158.0℃ |
| Ferveret | 450.8±45.0℃ |
| Density | 1.11±0.1 g/cm3 |
| Imprimis rotationis [α]20/D | +390.0° ad +430.0° (C=1, CHCL3). |
| Repono Nativ. | Reponunt in volutpat Temperature |
| HS Code* | 2937290099 |
| COA & MSDS | Praesto |
| Classification | Steroids Compone |
| Brand | Ruifu Chemical |
| Items | Specifications | Proventus |
| Aspectus | Pallida Crystallina pulveris | Conformare |
| Lepidium sativum | A: IR;B: RT (HPLC) | Conformare |
| Liquescens punctum | ≥158℃ | 161 |
| Substantiae cognatae (HPLC) |
|
|
| Relative Retention Time=0.81 | <0.40% | 0.17% |
| Relativum retentionis Time=1.34 | <0.40% | Conformare |
| Incognita Singula | <0.10% | 0.04% |
| Totalis immunditias | <1.00% | 0.29% |
| Damnum in Siccatio | <0.50% | 0.05% |
| Puritas / Analysis Methodus | >99.0% | 99.71% |
| Infrared Imaginis | Conformat ut Structure | |
| Test Standard | Enterprise Standard | |
| Pelagus Ritus | Immunditia Exemestanae (CAS: 107868-30-4) | |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Copia in vasis obsignatis ad frigus, siccum et ventilatas horreis ab substantiis non repugnantibus.A luce et humore protege.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
6-Methyleneandrost-4-ene-3,17-Dione (1,2-Dihydro Exemestane) (CAS: 19457-55-7) media est / immunditia Exemestanae (CAS: 107868-30-4).Exemestane est immedicabile steroid aromatase inhibitoris.Eius structura similis est cum subiecto naturali aromatasi, androstenedione, et pseudosubstrato agit.Postmenopausale feminarum estrogenium maxime convertitur ab androgenio (ex cortex adrenali producto) ab aromatasi in textus circumiacentibus.Hoc medicamentum irreversibiliter obligat cum situ activo in aromatasi ut illud deprimat, ita dramatically inferiores estrogen gradus in circulatione sanguinis mulierum postmenopausalis.Inhibendo aromatasi ad gradus inferiores estrogen, adhiberi potest ut cancer mammae dependens hormone-dependens in mulieribus postmenopausalibus.
